期刊
CANCER GENETICS AND CYTOGENETICS
卷 193, 期 1, 页码 19-28出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cancergencyto.2009.03.016
关键词
-
资金
- Intramural Research Program of the National Institutes of Health
- National Cancer Institute
- Deutsche Forschungsgerneinschaft [KFO 179]
Standard treatment of rectal cancer patients comprises preoperative chemoradiotherapy followed by radical surgery. However, clinicians are faced with the problem that response rates vary from one individual to another. Predictive biomarkers would therefore be helpful. To identify genomic imbalances that might assist in stratifying tumors into responsive or nonresponsive categories, we used metaphase comparative genomic hybridization to prospectively analyze pretherapeutic biopsies from 42 patients with locally advanced rectal cancers. These patients were subsequently treated with 5-fluorouracil-based preoperative chemoradiotherapy. Based on downsizing of the T-category, 21 rectal cancers were later classified as responsive, while the other 21 were nonresponsive. Comparing these two groups, we could show that gains of chromosomal regions 7q32 similar to q36 and 7q11 similar to q31, as well as amplifications of 20q11 similar to q13, were significantly associated with responsiveness to preoperative chemoradiotherapy (P < 0.05). However, the probability of detecting these copy number changes by chance is high (P = 0.21). Our primary results suggest that pretherapeutic evaluation of chromosomal copy number changes may be of value for response prediction of rectal cancers to preoperative chemoradiotherapy. This will require validation in a larger cohort of patients. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据